Home 2023

Gene editing

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
Forwarding Allogeneic Therapies
Bioprocessing

Forwarding Allogeneic Therapies

John Sterling -
0
Integrated DNA Technologies Opens Therapeutic Manufacturing Facility
Bioprocessing

Integrated DNA Technologies Opens Therapeutic Manufacturing Facility

John Sterling -
0
Avian Flu Target in Chickens Disguised by CRISPR
Genome Editing

Avian Flu Target in Chickens Disguised by CRISPR

Julianna LeMieux, PhD -
0
At Chardan Conference, David Liu Foresees First Prime Editing Clinical Trial in 2024
GEN Edge

At Chardan Conference, David Liu Foresees First Prime Editing Clinical Trial in 2024

Alex Philippidis -
0
New Drugs May Help Rebuild Momentum against Cardiovascular Disease
Insights

New Drugs May Help Rebuild Momentum against Cardiovascular Disease

Kathy Vuksanaj -
0
Compact Gene-Editing Enzyme Could Enable More Effective Clinical Therapies
Featured

Compact Gene-Editing Enzyme Could Enable More Effective Clinical Therapies

Sophia Ktori -
0
CRISPR Cures 2033: Expanding the Public Health Impact of Gene Editing
Genome Editing

CRISPR Cures 2033: Expanding the Public Health Impact of Gene Editing

Kathy Vuksanaj -
0
BioProcess International Showcases the Unsung Heroes of Drug Development
Bioprocessing

BioProcess International Showcases the Unsung Heroes of Drug Development

Julianna LeMieux, PhD -
0
CRISPR Silkworms Make Spider Silk That Defies Scientific Constraints
Genome Editing

CRISPR Silkworms Make Spider Silk That Defies Scientific Constraints

Jonathan D Grinstein, PhD -
0
123...167Page 1 of 167
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.